Related Experiment Video
Updated: May 31, 2026

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism
Holger Henneicke1, Markus Herrmann, Robert Kalak
1Bone Research Program, ANZAC Research Institute, The University of Sydney, Sydney, Australia.
Background:
The pathogenesis of glucocorticoid-induced osteoporosis remains ill defined. In this study, we examined the role of the osteoblast in mediating the effects of exogenous glucocorticoids on cortical and trabecular bone, employing the Col2.3-11βHSD2 transgenic mouse model of osteoblast-targeted disruption of glucocorticoid signalling.
Methods:
Eight week-old male transgenic (tg) and wild-type (WT) mice (n=20-23/group) were treated with either 1.5 mg corticosterone (CS) or placebo for 4 weeks. Serum tartrate-resistant acid phosphatase 5b (TRAP5b) and osteocalcin (OCN) were measured throughout the study. Tibiae and lumbar vertebrae were analysed by micro-CT and histomorphometry at endpoint.
Results:
CS suppressed serum OCN levels in WT and tg mice, although they remained higher in tg animals at all time points (p<0.05). Serum TRAP5b levels increased in WT mice only. The effect of CS on cortical bone differed by site: At the endosteal surface, exposure to CS significantly increased bone resorption and reduced bone formation, resulting in a larger bone marrow cavity cross-sectional area (p<0.01). In contrast, at the pericortical surface bone resorption was significantly decreased accompanied with a significant increase in pericortical cross-sectional area (p<0.05) while bone formation remained unaffected. Vertebral cortical thickness and area were reduced in CS treatment mice. Tg mice were partially protected from the effects of exogenous CS, both on a cellular and structural level. At the CS doses used in this study, trabecular bone remained largely unaffected.
Conclusion:
Endocortical osteoblasts appear to be particularly sensitive to the detrimental actions of exogenous glucocorticoids. The increase in tibial pericortical cross-sectional area and the according changes in pericortical circumference suggest an anabolic bone response to GC treatment at this site. The protection of tg mice from these effects indicates that both catabolic and anabolic action of glucocorticoids are, at least in part, mediated by osteoblasts.
Insights
Glucocorticoids negatively impact bone by affecting osteoblasts, particularly at the endosteal surface. However, a protective effect was observed at the pericortical surface, suggesting complex bone remodeling responses to these steroids.
Area of Science:
- Endocrinology
- Bone Biology
- Osteoporosis Research
Background:
- Glucocorticoid-induced osteoporosis pathogenesis is not fully understood.
- Osteoblasts play a key role in mediating glucocorticoid effects on bone.
- A transgenic mouse model with targeted disruption of glucocorticoid signaling in osteoblasts was utilized.
Purpose of the Study:
- To investigate the role of osteoblasts in glucocorticoid-induced bone changes.
- To analyze the effects of exogenous glucocorticoids on cortical and trabecular bone.
- To evaluate the protective capacity of osteoblast-targeted glucocorticoid signaling disruption.
Main Methods:
- Treatment of wild-type (WT) and transgenic (tg) mice with corticosterone (CS) or placebo.
- Measurement of serum bone turnover markers (TRAP5b, OCN).
- Analysis of bone structure using micro-CT and histomorphometry.
Main Results:
- CS suppressed osteocalcin in both WT and tg mice, with higher levels in tg mice.
- Corticosterone increased bone resorption and decreased formation at the endosteal surface but decreased resorption at the pericortical surface.
- Transgenic mice showed partial protection against CS effects, while trabecular bone remained largely unaffected.
Conclusions:
- Endocortical osteoblasts are highly sensitive to glucocorticoid-induced bone loss.
- Pericortical bone exhibits an anabolic response to glucocorticoids.
- Osteoblasts mediate both the catabolic and anabolic actions of glucocorticoids.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Cushing Syndrome I: Introduction
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Cushing Syndrome II: Pathophysiology
